06/30/2004 - The Pew Initiative on Food and Biotechnology (PIFB) held a policy dialogue to engage thought leaders on the ethical and regulatory issues raised by the introduction of genetically modified (GM) animals. The dialogue looked at some of the more compelling ethical arguments for and against GM animals (including patients rights and animal welfare concerns), what is known about consumer opinion on these "next generation" products of agricultural biotechnology as well as the role of regulation. Particular attention was paid to the ability of the regulatory system to simultaneously guide producers and advance innovation, while safeguarding the food supply and the environment.
David Magnus, a bioethicist with the Stanford Medical Center, will address the broad range of bioethical issues raised by GM animals including patients' advocacy and animal welfare concerns.
Carole Tucker-Foreman, Director of the Food Policy Institute at the Consumer Federation of America, will share her thoughts on consumer opinion about GM animals.
Fred Degnan, a partner of King & Spalding, will provide counsel on the legislation and authorities which could be used to regulate GM animals.
Joe McGonigle, VP of Business Development at Aqua Bounty Farms, will talk about the company's experience working with the US regulators to bring transgenic salmon to market.
John Phillips, one of the creators of EnviroPig and an academic with the University of Guelph, will identify the key pieces of a strong regulatory system that enables producers to successfully bring products to market.
Michael Rodemeyer, Executive Director of the Pew Initiative on Food and Biotechnology will moderate the panel.